M&A Deal Summary

Avista Capital Partners Acquires WellSpring Consumer Healthcare

On August 23, 2022, private equity firm Avista Capital Partners acquired medical products company WellSpring Consumer Healthcare from Audax Private Equity

Acquisition Highlights
  • This is Avista Capital Partners’ 8th transaction in the Medical Products sector.
  • This is Avista Capital Partners’ 41st transaction in the United States.
  • This is Avista Capital Partners’ 1st transaction in Florida.

M&A Deal Summary
Date 2022-08-23
Target WellSpring Consumer Healthcare
Sector Medical Products
Buyer(s) Avista Capital Partners
Sellers(s) Audax Private Equity
Deal Type Secondary Buyout

Target

WellSpring Consumer Healthcare

Sarasota, Florida, United States
website
WellSpring Consumer Healthcare is a marketer of over-the-counter and cosmetic brands in the skincare, feminine hygiene, and gastrointestinal care categories. WellSpring’s portfolio includes Bactine, Bonine, FDS, Emetrol, Micatin, Gelusil, Glaxal Base, Barriere, and K-Lyte. WellSpring Consumer Healthcare was founded in 1999 and is based in Sarasota, Florida.

Search 193,092 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Avista Capital Partners

New York, New York, United States

website

Category Private Equity Firm
Founded 2005
PE ASSETS 6.0B USD
Size Mega
Type Sector Focused
DESCRIPTION

Avista Capital Partners is a private investment firm formed by a group of professionals with roots from DLJ Merchant Banking Partners. Avista makes controlling and minority investments in US based energy, healthcare, and media companies with revenues greater than $25 million. Typical transactions include leverage buyouts, build-ups, and growth capital financings. Avista Capital was formed in 2005 and is based in New York City with an additional office in Houston, Texas.

DEAL STATS #
Overall 50 of 53
Sector (Medical Products) 8 of 8
Type (Secondary Buyout) 15 of 18
State (Florida) 1 of 1
Country (United States) 41 of 43
Year (2022) 2 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-04-18 Inform Diagnostics

Irving, Texas, United States

Inform Diagnostics is a provider of anatomic pathology services primarily in the fields of gastroenterology, dermatology, hematology, breast health, and urology. The company's team of more than 90 distinguished expert subspecialists utilizes state-of-the-art pathology laboratories to serve more than 5,500 patients every day. Inform Diagnostics continuously improves diagnostic accuracy through consensus-based terminology and criteria, rigorous quality assurance, daily consensus conferences, extensive educational and training activities, and close relationships with clinical partners. Inform Diagnostics was formed in 1996 and is based in Irving, Texas.

Sell $170M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-11-01 Taconic Biosciences

Hudson, New York, United States

Taconic Biosciences is a provider of genetically engineered models and service solutions used in life sciences research. Taconic provides murine solutions so that customers can acquire, custom generate, breed, precondition, test, and distribute valuable research models worldwide. Taconic Biosciences was founded in 1952 and is based in Hudson, New York.

Buy -

Seller(S) 1

SELLER

Audax Private Equity

Boston, Massachusetts, United States

Investor Investor Investor Investor Investor

website

Category Private Equity Firm
Founded 1999
PE ASSETS 16.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Audax Private Equity is a private equity firm focused on acquiring control positions in a variety of mid to large North American headquartered companies. The Firm segments its activities into lower middle-market and larger scale investing. Within its larger group, Audax targets profitable businesses valued up to $800 million and within its lower middle-market group, the Firm seeks companies valued up to $125 million. Sectors of interest include business services, consumer products/services, financial services, healthcare services, industrial services, software, and technology. Audax has a special interest in businesses that can benefit from a buy and build investment strategy for growth. Audax Private Equity was formed in 1999 and is based in Boston, Massachusetts.

DEAL STATS #
Overall 93 of 97
Sector (Medical Products) 6 of 6
Type (Secondary Buyout) 53 of 53
State (Florida) 7 of 7
Country (United States) 88 of 92
Year (2022) 6 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-08-15 Rensa Filtration

St. Charles, Illinois, United States

Rensa Filtration is a designer and manufacturer of air filtration products and services for commercial and industrial applications. Rensa Filtration is based in St. Charles, Illinois.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-09-12 DISA

Houston, Texas, United States

DISA is specializes in providing a comprehensive suite of employee testing, screening, and compliance management solutions to a diverse set of end markets. DISA was founded in 1987 and is based in Houston, Texas.

Buy -
Mergr

Product

Company

Legal